During the past decade, Synexus Clinical Research GmbH conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 10 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Synexus Clinical Research GmbH" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Celgene" with 2 trials sponsored and "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Synexus Clinical Research GmbH" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator and "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Synexus Clinical Research GmbH" are "Cardiovascular Disease" (2 trials), "Eosinophilic Esophagitis" (2 trials), "Insomnia Disorder" (2 trials), "Psoriasis" (2 trials) and "Acute Pain" (1 trials). Many other conditions were trialed in "Synexus Clinical Research GmbH" in a lesser frequency.

Most popular intervention types in "Synexus Clinical Research GmbH" are "Drug" (17 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "BMS-986165" (2 trials), "CC-93538" (2 trials), "Guselkumab Dose 1" (2 trials) and "Guselkumab Dose 2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Synexus Clinical Research GmbH" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Synexus Clinical Research GmbH". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Synexus Clinical Research GmbH, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Synexus Clinical Research GmbH, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".